Medior SRL
Medior reported total assets of €1.42m at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Aug 2026).
The score of Medior shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +15 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medior's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Aug 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 21 Jun 2024
- Year ended 31 Dec 2022filed on 17 Jul 2023
- Year ended 31 Dec 2021filed on 16 Jun 2022
Medior's financial analysis
- Solvency92.9%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medior
Medior's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0453.517.065
- VAT number
- BE0453517065
- Peppol
- Registered · 0208:0453517065 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Oct 1994
- Registered office
- 3910 Pelt
- Latest accounts
- 2025 · filed on 14 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Medior (SRL) has been based in Pelt since 1994, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 61,778 € and equity of €1.32m; its revenue is not published. Its solvency stands at 92.9%, above the median of its sector (46.0%).
Companies similar to Medior
Companies in the same business, of comparable size and area, outside its group.
- Hyloris Wholesale of pharmaceutical and medical goods Liège · balance sheet €1.58m
- AT - Medicals Wholesale of pharmaceutical and medical goods Hulshout · balance sheet €1.38m
- Cirba Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 67,062 €
- H.D.P. Medical Wholesale of pharmaceutical and medical goods Waasmunster · balance sheet €1.32m
- Rembrandt Medical Wholesale of pharmaceutical and medical goods Nazareth · balance sheet €1.08m
- Biotechnological Enzymatic Catalyse Wholesale of pharmaceutical and medical goods Merelbeke-Melle · balance sheet €1.22m
- Esteve Pharmaceuticals Wholesale of pharmaceutical and medical goods Jette · balance sheet €2.91m
- ALL Products Wholesale of pharmaceutical and medical goods Aalst · balance sheet 972,749 €
Frequently asked questions about Medior
What is the revenue of Medior?
Medior files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medior?
In Belgium, the VAT number is the company number prefixed with BE: BE0453517065 for Medior, if the company is VAT-registered. Its company number (CBE) is 0453.517.065.
Where is the registered office of Medior?
According to the CBE register, the registered office of Medior is in 3910 Pelt.
What is the equity of Medior?
At the close of the 2025 financial year, the equity of Medior amounts to 1,321,270 €, a solvency of 92.9% of total assets.
Who manages Medior?
The register lists 2 active mandates at Medior. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medior
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →